Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous ...

The Evolution Summit is designed to address the most pressing challenges and opportunities in clinical trials, with a focus ...

US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has formally signed off on a recommendation to remove ...

Agentic AI refers to AI systems that add layers of reason and autonomy. They act as largely independent agents that are ...

The 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to ...

June was a slower month on the pharma agency side, but were several hires worth reporting, as well as a couple of interesting appointments on the non-profit side.

The second healthcare sector IPCEI – approving up to €403 million of State aid by five Member States, including France, ...

Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

Using microneedle arrays developed at Carnegie Melon, microdosed with a known chemotherapeutic agent delivered directly to ...